Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Microdose Probe Drugs in Healthy Volunteers and Renal Impairment Patients
NCT05747768Phase 4Unknown
- Sponsor
- Peking University Third Hospital
- Start
- Jul 2022
- Primary completion
- Jun 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of midazolam, dabigatran, pitavastatin, rosuvastatin, atorvastatin, sponsored by Peking University Third Hospital. Status: unknown.
02
Drugs
midazolamdabigatranpitavastatinrosuvastatinatorvastatin
Beyond the preview
Go deeper on NCT05747768.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05747768.